Alzheimer’s/Dementia – Page 13

Saturday, November 23, 2024

Latest:

Aging Alzheimer's/Dementia FDA Part D/Prescription Drugs

Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?

(By Judith Graham for Kaiser Health News) The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining

(By Daniel R. George and Peter Whitehouse for STAT) Billions of dollars have been spent in pursuit of a pharmaceutical

More than six million Americans are living with Alzheimer’s disease. By 2050, This number is projected to rise to nearly

(By Rachel Cohrs for STAT) WASHINGTON — Lawmakers have requested data and documents from the Food and Drug Administration related

Biogen, Inc., the maker of the controversial and expensive new Alzheimer’s drug, is offering the medication free of charge for

In a recent study published in Nature Neuroscience, researchers said, “if we understood why these neurons are so vulnerable, maybe

Around 6.2 million Americans aged 65 and older are living with Alzheimer’s disease. With no effective interventions for disease prevention

(By Judith Graham for Kaiser Health News) As covid-19 resurges across the country, driven by the highly infectious delta variant,

(Source – www.blogs.va.gov) Researchers with the VA Bedford and VA Boston health care systems have developed a non-invasive optical technique

(By Andrew Joseph and Rachel Cohrs for STAT) For all the explosive controversy over the approval of the first treatment